pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

5,256 catalysts · 5,256 phase readout · 2,323 8k filing · 321 pdufa · 259 earnings · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 0 catalysts2026-07-29: 0 catalysts2026-07-30: 52 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 13 catalysts2026-08-05: 16 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 1 catalyst2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 1 catalyst2026-10-22: 2 catalysts2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: patent expiry×type: phase readout×clear all
type
  • phase readout5,256
  • 8k filing2,323
  • pdufa321
  • earnings259
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›ACTIVE_NOT_RECRUITINGphase readoutNCT06189183: Adjuvant Hypofractionation Radiotherapy for Thymic Epithelial Tumours After Complete Resection

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences. Phase: NA. Conditions: Thymus Neoplasms

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06854094: Consolidation Therapy With Cladribine in Relapsing Multiple Sclerosis Patients

Sponsor: Ente Ospedaliero Cantonale, Bellinzona. Phase: . Conditions: Multiple Sclerosis

full page →ctgov ↗
›COMPLETEDphase readoutNCT06857994: The Association Between Cognitive Function and Neuropathy in Individuals With Type 2 Diabetes

Sponsor: Steno Diabetes Center Copenhagen. Phase: . Conditions: Peripheral Diabetic Neuropathy, Cardiovascular Autonomic Neuropathy, Cognitive Impairment, Diabetes Type 2

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04634266: TRICuspid Intervention in Heart Failure Trial

Sponsor: LMU Klinikum. Phase: NA. Conditions: Heart Failure Attributable to Severe Tricuspid Regurgitation

full page →ctgov ↗
›COMPLETEDphase readoutNCT03038022: Study of MGL-3196 in Patients With Heterozygous Familial Hypercholesterolemia (HeFH)

Sponsor: Madrigal Pharmaceuticals, Inc.. Phase: PHASE2. Conditions: Heterozygous Familial Hypercholesterolemia

full page →ctgov ↗
›COMPLETEDphase readoutNCT06931522: Effects of Mat and Reformer Pilates in Multiple Sclerosis

Sponsor: Gazi University. Phase: NA. Conditions: Multiple Sclerosis

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07619222: Correlation and Prognostic Value of Body Composition, Cardiac Structure and Function in Patients With Different Heart Failure Subtypes

Sponsor: Beijing Anzhen Hospital. Phase: . Conditions: Heart Failure

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT07373951: Retrospective Multicenter Study of Patient-level T1CE/FLAIR MRI Deep Learning to Predict EGFR/ALK Driver Status in NSCLC Brain Metastases With External Validation and Survival Analysis

Sponsor: Ming Yang. Phase: . Conditions: Non-Small Cell Lung Cancer, Brain Metastases

full page →ctgov ↗
›RECRUITINGphase readoutNCT06270251: Modeling Tic Change During Behavior Therapy for Tics

Sponsor: University of Minnesota. Phase: NA. Conditions: Chronic Tic Disorder

full page →ctgov ↗
›COMPLETEDphase readoutNCT06289829: The Appropriate Remifentanil Dose for Optimal Insertion of Laryngeal Mask Airway in Adult Patients During Induction of General Anesthesia Using Remimazolam.

Sponsor: Yonsei University. Phase: NA. Conditions: Adult, Laryngeal Masks, Remimazolam, Remifentanil

full page →ctgov ↗
›COMPLETEDphase readoutNCT07376031: Cervical Thermal Ablation to Treat Persistent HPV Infection

Sponsor: Hvidovre University Hospital. Phase: NA. Conditions: Cervical Cancer Screening, HPV, Thermal Ablation

full page →ctgov ↗
›COMPLETEDphase readoutNCT07656402: Role Model-Based Ethics Education and Moral Injury Prevention in Second-Year Medical Students

Sponsor: Chun Lun Hsu. Phase: NA. Conditions: Moral Injury, Perceived Stress, Resilience, Ethics Education

full page →ctgov ↗
›RECRUITINGphase readoutNCT06736002: Effects of Mega-dose Vitamin D Pulse and Maintenance Therapy on Seizure Frequency, Fatigue, and Quality of Life: A Prospective Study

Sponsor: Chin-Wei Huang. Phase: NA. Conditions: Epilepsy

full page →ctgov ↗
›COMPLETEDphase readoutNCT07481045: Compensatory Inferior Turbinate Surgery in Septorhinoplasty

Sponsor: Saglik Bilimleri Universitesi. Phase: NA. Conditions: Nasal Obstruction Septal Deviation Compensatory Inferior Turbinate Hypertrophy

full page →ctgov ↗
›TERMINATEDphase readoutNCT04222972: A Study of Pralsetinib Versus Standard of Care for First-Line Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC)

Sponsor: Hoffmann-La Roche. Phase: PHASE3. Conditions: RET-fusion Non Small Cell Lung Cancer, Lung Neoplasm, Carcinoma, Non-Small-Cell Lung, Respiratory Tract Neoplasms, Thoracic Neoplasms, Neoplasms by Site, Neoplasms, Lung Diseases, Respiratory Tract Disease, Carcinoma, Bronchogenic, Bronchial Diseases, Head and Neck Neoplasms, Adenocarcinoma, Carcinoma, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue

full page →ctgov ↗
›RECRUITINGphase readoutNCT07362095: Luspatercept for the Treatment of Anemia Following Allogeneic Hematopoietic Stem Cell Transplantation(Allo-HSCT)

Sponsor: Zhujiang Hospital. Phase: PHASE1. Conditions: Acute Leukemia

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07167277: The Impact of Whey Protein on Frailty in Older Adults Classified as Pre-frail

Sponsor: University of Kansas Medical Center. Phase: NA. Conditions: Pre-frail, Pre-Frail Older Adults, Cognition, Physical Function, Dietary Intake Assessment, MRI

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07593677: Motivating Activity Through Text Communications - Helping Adults Increase Movement

Sponsor: University of Michigan. Phase: NA. Conditions: Physical Inactivity, Aging, Cognitive Ability, Behavior Change

full page →ctgov ↗
›COMPLETEDphase readoutNCT03604757: 68Ga-RM2 Compared to 68Ga-PSMA-617 PET/CT for Prostate Cancer Imaging According to Various Metastatic Risks

Sponsor: University Hospital, Bordeaux. Phase: PHASE2. Conditions: Prostate Cancer

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07350057: A Preliminary Clinical Study on the Efficacy of Cyclophosphamide and Sirolimus Combined With VIC-1911 in Preventing Graft-versus-Host Disease After Haploidentical Stem Cell Transplantation in Children

Sponsor: Shanghai Jiao Tong University School of Medicine. Phase: PHASE1. Conditions: GVHD (Acute or Chronic)

full page →ctgov ↗
›COMPLETEDphase readoutNCT07386301: Open Membrane Technique as an Innovative Minimally Invasive Technique for Bone Augmentation

Sponsor: Saint-Joseph University. Phase: NA. Conditions: Bone Graft, Keratinized Tissue

full page →ctgov ↗
›RECRUITINGphase readoutNCT07260812: KSV01 Injection for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Sponsor: TCRx Therapeutics Co.Ltd. Phase: PHASE1. Conditions: Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma (DLBCL)

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT00119912: NORCCAP: Norwegian Colorectal Cancer Prevention Trial

Sponsor: Norwegian Institute of Public Health. Phase: NA. Conditions: Colorectal Cancer, Adenoma

full page →ctgov ↗
›RECRUITINGphase readoutNCT07540312: A Prospective Trial of a Variable Compression System for Moderate to Severe Irritable Bowel Syndrome

Sponsor: PGP Health. Phase: NA. Conditions: IBS (Irritable Bowel Syndrome)

full page →ctgov ↗
›RECRUITINGphase readoutNCT05728281: Impact of Time on Sexual Function (FSFI® Score) After Hysterectomy

Sponsor: University Hospital, Angers. Phase: NA. Conditions: Time Between Hysterectomy and Resumption of Sexual Relations, Sexual Function

full page →ctgov ↗
›RECRUITINGphase readoutNCT07481981: A Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Arterial Hypertension (PAH)

Sponsor: Insmed Incorporated. Phase: PHASE3. Conditions: Pulmonary Arterial Hypertension

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07594730: Brief Intervention Addressing Stigma Among Parents of Children With Mental Health Problems

Sponsor: New York State Psychiatric Institute. Phase: NA. Conditions: Depression Disorders, ADHD, Substance Abuse, Social Stigma, Help-Seeking Behavior, Caregiver Burden

full page →ctgov ↗
›COMPLETEDphase readoutNCT02361528: GM-CSF to Decrease ICU Acquired Infections

Sponsor: Hospices Civils de Lyon. Phase: PHASE3. Conditions: Septic Shock, Severe Sepsis

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07322328: Effect of Hypo-pressive Exercises and Pelvic Floor Muscle Training in Postpartum Stress Urinary Incontinence Women

Sponsor: Lahore University of Biological and Applied Sciences. Phase: NA. Conditions: Stress Urinary Incontinence (SUI), Stress Urinary Incontinence in Women

full page →ctgov ↗
›COMPLETEDphase readoutNCT05005728: XmAb®20717 (Vudalimab) Alone or in Combination With Chemotherapy or Targeted Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer

Sponsor: Xencor, Inc.. Phase: PHASE2. Conditions: Metastatic Castration-Resistant Prostate Cancer

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04454528: BreastVAX: Radiation Boost to Enhance Immune Checkpoint Blockade Therapy

Sponsor: Abramson Cancer Center at Penn Medicine. Phase: PHASE1. Conditions: Breast Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT07537465: Mirror Therapy for Complex Regional Pain Syndrome in Stroke Patients

Sponsor: Başakşehir Çam & Sakura City Hospital. Phase: NA. Conditions: Stroke, Complex Regional Pain Syndrome I (CRPS I), Mirror Therapy

full page →ctgov ↗
›RECRUITINGphase readoutNCT07156565: Actinium Therapy for Late-stage Aggressive Sarcomas

Sponsor: Ratio Therapeutics, Inc.. Phase: PHASE1. Conditions: Advanced Soft Tissue Sarcoma

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT07563842: Updated Abdominal Compartment Society Consensus Definitions

Sponsor: Medical University of Lublin. Phase: . Conditions: Abdominal Hypertension, Abdominal Compartment Syndrome

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07446686: Study on the Safety and Tolerability of Postoperative Radiotherapy Concurrent With CDK4/6 Inhibitors in HR+/HER2- High-Risk Breast Cancer

Sponsor: Guizhou Provincial People's Hospital. Phase: EARLY_PHASE1. Conditions: Breast Cancer

full page →ctgov ↗
›TERMINATEDphase readoutNCT03684486: Rehabilitation by Effort for Patients With Advanced Bronchial Cancer

Sponsor: University Hospital, Toulouse. Phase: NA. Conditions: Bronchial Cancer, Malignant Mesothelioma

full page →ctgov ↗
›RECRUITINGphase readoutNCT04643041: Watch and Wait in PD-1 Monoclonal Antibody Treated dMMR/MSI-H Distal Rectal Cancer

Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University. Phase: NA. Conditions: Rectal Cancer

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07458841: Nurse-Led Discharge Program and Primary Care Outcomes: A Proof-of-concept Cluster Randomized Controlled Trial

Sponsor: The University of Hong Kong. Phase: NA. Conditions: Primary Healthcare

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05746273: Depressed Mood Improvement Through Nicotine Dosing 3

Sponsor: Vanderbilt University Medical Center. Phase: PHASE2. Conditions: Depressive Disorder

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06715241: A MULTICENTER, SEEKING SIGNAL, RANDOMISED, OPEN-LABEL PHASE II OF RELATLIMAB AND NIVOLUMAB VS NIVOLUMAB ALONE IN LOCALLY ADVANCED CERVICAL CANCERS

Sponsor: ARCAGY/ GINECO GROUP. Phase: PHASE2. Conditions: LOCALLY ADVANCED CERVICAL CANCERS

full page →ctgov ↗
›RECRUITINGphase readoutNCT07465341: Michigan Weight Navigation Program (MiWeigh) Study

Sponsor: University of Michigan. Phase: NA. Conditions: Obesity

full page →ctgov ↗
›RECRUITINGphase readoutNCT07429305: Combined Tibial Nerve Stimulation and Standing for People With SCI

Sponsor: University of British Columbia. Phase: NA. Conditions: Spinal Cord Injury

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07511894: Beta-Blockers on the Efficacy of Neoadjuvant Immunotherapy for Gastric Cancer

Sponsor: Nanfang Hospital, Southern Medical University. Phase: PHASE2. Conditions: Gastric Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT05358951: Sleep Treatment Education Program for Young Adult Cancer Survivors (STEP-YA)

Sponsor: Dana-Farber Cancer Institute. Phase: NA. Conditions: Insomnia, Insomnia Due to Medical Condition, Cancer

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07476729: International Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 (IntReALL BCP 2020)

Sponsor: Charite University, Berlin, Germany. Phase: PHASE3. Conditions: B-Cell Acute Lymphoblastic Leukaemia

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05600829: A Behavioural Weight Loss Intervention Delivered in Cardiac Rehabilitation for Patients With Atrial Fibrillation and Obesity

Sponsor: University of Calgary. Phase: NA. Conditions: Atrial Fibrillation, Obesity

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT06737237: Cervical Plexus Versus Infiltration for Clavicular Operations (CERPICO)

Sponsor: Naval Medical Center Camp Lejeune. Phase: NA. Conditions: Clavicle Surgery, Clavicle Fracture, Acromioclavicular Joint, Coracoclavicular Ligament

full page →ctgov ↗
›RECRUITINGphase readoutNCT03870672: rTMS Plus CCFES-mediated Functional Task Practice for Severe Stroke

Sponsor: The Cleveland Clinic. Phase: NA. Conditions: Stroke, Hemiplegia, Cerebrovascular Accident (CVA), Hemiparesis

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06126172: Radiomics of Treatment-naive Prostate Cancer Patients on Multiparametric MRI for Risk Stratification and Treatment Outcomes Predictions

Sponsor: Chang Gung Memorial Hospital. Phase: NA. Conditions: Prostate Cancer

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05310695: A Multicentre Randomised Controlled Trial of the Norwegian Health in Work Service. The NSAC Efficacy Study

Sponsor: Nordlandssykehuset HF. Phase: NA. Conditions: Musculoskeletal Disorder, Anxiety Disorders, Depression, Fatigue, Pain, Occupational Exposure, Work Related Stress, Workplace Bullying, Employment, Sickness Absence, Return to Work

full page →ctgov ↗
← prev
page 70 of 106
next →